Sales Information Business Analyst at Aleracare – TAYLORSVILLE, Utah

About PURE

Pure Infusion Suites is a fast-growing healthcare start-up, recognized as the fastest-growing company in Utah as of October 2024. Our success comes from our remarkable team, shared values, and a supportive culture that shows in every interaction, whether with patients in our clinics or with insurance companies and vendors at our corporate headquarters. If you are detail-oriented, self-directed, and passionate about ensuring claims are processed quickly and accurately, this could be the perfect role for you.

OUR CORE VALUES
We live by four core values that define our culture and guide our hiring:

· People-obsessed

· Passionate

· Builder

· Grateful

AleraCare and Pure Infusions are building a national, data-driven ambulatory infusion platform focused on disciplined growth, optimal payer mix, and strong site-level economics. The Sales Information Business Analyst (SIBA) plays a critical role in transforming data into actionable insights that guide geographic expansion, sales deployment, and clinic-level profitability

The SIBA functions as the analytical backbone for commercial decision-making, supporting growth strategy, sales performance optimization, payer-mix improvement, and infusion-chair utilization across the enterprise.

• Analyze demographic, payer, and referral data to identify markets with strong commercial-insurance concentration.
• Support de novo expansion, clinic relocation, and market prioritization using payer mix, disease prevalence, referral density, and competitive landscape analysis.
• Build market scorecards assessing commercial vs. government payer mix, margin potential, and expected ramp timelines.

• Conduct post-mortem analyses of payer mix by sales representative, clinic, and market.
• Identify drivers of suboptimal payer mix and low-margin volume.
• Partner with Sales Leadership to deliver data-backed coaching, territory refinements, and targeting strategies.
• Develop dashboards tracking commercial vs. government payer ratios, revenue per infusion, and gross profit by referral source.
• Compensation plan development and analytics (including modeling, scenario testing, and ROI analysis).
• Reporting and processing of commissions, ensuring accuracy, transparency, and alignment with sales performance metrics.

3. Formulary & Drug-Mix Strategy (New):

• Analyze drug-level profitability and reimbursement to support formulary development and optimization.
• Identify the most profitable drug targets based on payer reimbursement, ASP spreads, patient mix, and market trends.
• Develop prioritization frameworks that guide Sales toward high-value therapies and referral sources.
• Partner with Clinical, Operations, and Sales teams to align formulary recommendations with site capabilities, payer rules, and margin objectives.

• Analyze infusion-chair utilization by site, daypart, and therapy mix.
• Identify capacity bottlenecks, underutilized chairs, and scheduling inefficiencies.
• Partner with Operations, Nursing, and Scheduling to optimize clinic hours, staffing models, and throughput for higher-margin therapies.

• Develop executive-ready dashboards and reporting packages for ELT, Board, and commercial leaders.
• Translate complex datasets into clear insights and actionable recommendations.
• Ensure data consistency and alignment across Sales, Finance, Operations, and RCM systems.

• Serve as a strategic partner to Sales, Commercial Strategy, Finance/FP&A, and Operations.
• Support the integration of legacy AleraCare and Pure Infusions datasets into a unified source of truth.
• Participate in quarterly and annual planning cycles.

Within 90 days, the SIBA is expected to:

• Establish a baseline enterprise view of payer mix, sales performance, and chair utilization.
• Deliver a standardized payer-mix performance dashboard adopted by Sales and ELT.
• Complete post-mortem analyses identifying key drivers of poor payer mix and low-margin volume, with actionable recommendations.
• Produce a market-prioritization model identifying high-value geographic opportunities based on commercial coverage, referral density, and margin potential.
• Identify and quantify at least three chair-utilization or capacity-optimization opportunities with clear EBITDA impact.
• Align cross-functional leaders on definitions, metrics, and reporting cadence to ensure a single source of truth.
• Present at least one executive-ready insight package to ELT or the Board translating analytics into growth or margin actions.

• Bachelor’s degree in Business, Analytics, Finance, Economics, or related field.
• 5+ years of experience in business analytics, sales analytics, or commercial intelligence (healthcare strongly preferred).
• Advanced proficiency in Excel and BI tools (Power BI, Tableau, Looker, or equivalent).
• Strong analytical mindset with ability to move from data to insight to action.

• Experience in ambulatory infusion, specialty pharmacy, home infusion, or multi-site healthcare services.
• Familiarity with payer-mix dynamics, referral-driven sales models, and capacity planning.
• Experience in private-equity-backed healthcare environments.

The SIBA directly influences AleraCare + Pure’s ability to grow in the right markets, improve commercial payer mix, maximize clinic capacity, and drive disciplined, data-driven growth decisions.